查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶
市場調查報告書
商品編碼
1562193

北美 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶

North America PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 140 Pages | 訂單完成後即時交付

價格

北美PCR技術市場預計將從2022年的50.7581億美元成長到2030年的96.3486億美元。

PCR 技術的進步推動北美 PCR 技術市場

PCR 的優點，例如靈敏度高、相對簡單性和成本效益高，在過去幾年中大大增加了它的受歡迎程度。 PCR 技術已經發生了顯著的發展，為各種應用帶來了更具體的工作流程。 PCR 技術正在探索多種非常規應用，使分子診斷變得更容易、更快捷。 dPCR 和 RT-PCR 的進步可用於診斷疾病、識別病毒和細菌以及協助法醫調查。研究人員正在嘗試使用一些奈米材料來減少測試時間。 2023 年 3 月，韓國科學技術研究院 (KIST) 智慧感測增強安全系統中心宣布開發出超快速 PCR 技術。該開發案由 Sang Kyung Kim 博士（董事）和 Seungwon Jung 博士的研究團隊領導。與先前利用光熱奈米材料進行的測試相比，超快速PCR將測試時間縮短了10倍。新方法的診斷效能與現有測試方法相當，並且可以在5分鐘內完成。 2021 年 1 月，丹納赫公司宣布加拿大衛生部向 Cepheid 頒發了用於 Xpert Xpress SARS-CoV-2/Flu/RSV 的醫療器材許可證。 PCR 技術市場中該公司的一些技術進步如下：2021 年 3 月，PCR Biosystems 宣布推出其 IsoFast Bst 聚合酶試劑，該試劑支援靈敏、穩健和快速的 RNA 和 DNA 擴增，從而實現更快的測試程序。 2021 年 10 月，Thermo Fisher Scientific 推出了 Applied Biosystem Quantstudio Absolute Q-Digital PCR 系統，這是第一個完全整合的 dPCR 系統，旨在提供高度準確且一致的遺傳分析。該公司聲稱該產品可在 90 分鐘內產生研究結果。 2022 年 5 月，Bio-Rad Laboratories, Inc. 在接受 CE 標誌的選定國家推出了 CFX Duet 即時 PCR 系統。該系統旨在支持研究人員開發單重和雙重 qPCR 檢測。 2022年11月，PCR Biosystems推出了新的qPCR試劑混合物－Clara Probe Mix、Clara Probe 1-Step Mix和Clara HRM Mix。 2022年11月，Cepheid推出了Xpert Xpress MVP多重PCR測試。此測試有助於從單一樣本中檢測與三種不同病症（即細菌性陰道炎(BV)、滴蟲病和外陰陰道念珠菌病）相關的生物體DNA，從而有助於更精確的診斷並支持準確的抗生素治療方案。因此，這些進步預計將在未來幾年為 PCR 技術市場帶來新趨勢。

北美 PCR 技術市場概況

北美 PCR 技術市場分為美國、加拿大和墨西哥。該地區的市場成長歸因於生物分析儀器製造商和 PCR 公司對創新產品的需求增加、主要市場參與者的存在以及各個學術和研究機構進行的廣泛研發。此外，在醫療保健操作中採用醫療設備來提高品質和降低成本的眾所周知的做法也有利於美國和其他北美國家的 PCR 技術市場。研究和治療中對 CRISPR 和 PCR 等基因合成和編輯工具的接受和採用激增，需要有助於快速定量、改變和觀察的檢測。液滴數位 PCR 形式的數位 PCR 的出現為篩選提供了新的機會，具有卓越的靈敏度和簡單的適應性。美國正在尋求公共和私人組織的大量資金，以鼓勵對先進研究方法的投資。例如，國際基因工程和生物技術中心旨在促進成員國之間的合作研究。它透過合作研究計劃（CRP）獲得資金，該計劃旨在解決相關和有趣的原始科學問題。生物技術的進步依賴 PCR 技術來幫助改善人類健康、動物福利和糧食安全。美國食品藥物管理局（USFDA）致力於確保生物技術產品的安全。美國積極參與各種研究團體和組織舉辦的科學會議、研討會和活動，幫助交流不同地區內基於PCR的趨勢和最新研究成果。因此，國家的積極參與也是推動PCR技術市場成長的因素之一。

北美 PCR 技術市場收入及 2030 年預測（百萬美元）

北美 PCR 技術市場細分

北美 PCR 技術市場分為技術、產品、應用、最終用戶和國家。

根據技術，北美 PCR 技術市場分為即時 PCR、常規 PCR、逆轉錄、數位 PCR、多重 RTPCR、熱啟動 PCR 等。 2022 年，即時 PCR 領域佔據北美 PCR 技術市場的最大佔有率。

就產品而言，北美 PCR 技術市場分為試劑和耗材、儀器以及軟體和服務。到2022年，試劑和耗材細分市場在北美PCR技術市場中佔據最大佔有率。此外，西林瓶尺寸分為0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，儀器部分分為桌上型 PCR 和攜帶式熱循環儀/PCR。

依應用分類，北美 PCR 技術市場分為基因表現分析、基因定序、基因分型、核酸合成、標準驗證、照護端診斷應用、環境應用等。 2022 年，基因表現分析領域佔據北美 PCR 技術市場的最大佔有率。

根據最終用戶，北美 PCR 技術市場分為醫院和診斷中心、製藥和生物技術公司、學術機構和研究實驗室等。 2022 年，醫院和診斷中心領域佔據北美 PCR 技術市場的最大佔有率。

依國家分類，北美 PCR 技術市場分為美國、加拿大和墨西哥。 2022 年，美國將主導北美 PCR 技術市場。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Atila Biosystems Inc、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc、Visby Medical Inc 和Ellume Ltd 是北美PCR 技術市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美 PCR 技術市場 - 主要產業動態

  • PCR 技術市場 - 主要產業動態
  • 市場促進因素
    • 遺傳性疾病和傳染病的盛行率不斷上升
    • PCR 技術的投資和資金供應激增
  • 市場限制
    • PCR 系統的高成本和替代檢測的可用性
  • 市場機會
    • POC 測試需求不斷增加
  • 未來趨勢
    • PCR 技術的進步
  • 促進因素和限制的影響：

第 5 章：PCR 技術市場 - 北美市場分析

  • PCR 技術市場收入，2020 - 2030

第 6 章：北美 PCR 技術市場分析 - 按技術

  • 概述
  • 即時螢光定量PCR
  • 常規PCR
  • 逆轉錄聚合酶連鎖反應
  • 數位PCR
  • 多重逆轉錄聚合酶連鎖反應
  • 熱啟動PCR
  • 其他

第 7 章：北美 PCR 技術市場分析 - 按產品

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按產品分類）（%）
  • 試劑及耗材
  • 儀器儀表
  • 軟體和服務

第 8 章：北美 PCR 技術市場分析 - 按應用

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率，按應用分類 (%)
  • 基因表現分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 標準驗證
  • 照護端診斷
  • 環境應用
  • 其他

第 9 章：北美 PCR 技術市場分析 - 按最終用戶

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診斷中心
  • 學術界及研究機構
  • 製藥和生物技術公司
  • 其他

第 10 章：北美 PCR 技術市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 11 章：PCR 技術市場-產業格局

  • 概述
  • PCR 技術市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Atila Biosystems Inc
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Visby Medical Inc
  • Ellume Ltd

第 13 章：附錄

Product Code: BMIRE00030517

The North America PCR technologies market is expected to grow from US$ 5,075.81 million in 2022 to US$ 9,634.86 million by 2030. It is estimated to record a CAGR of 8.3%from 2022 to 2030.

Advancements in PCR Technologies Fuel North America PCR Technologies Market

The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes. In January 2021, Danaher Corporation announced that Health Canada issued a medical device license to Cepheid for Xpert Xpress SARS-CoV-2/Flu/RSV. A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark. The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.

North America PCR Technologies Market Overview

The North America PCR technologies market is segmented into the US, Canada, and Mexico. Market growth in this region is attributed to the increased demand for innovative products from bioanalytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. In addition, the well-known practice of adopting medical devices in healthcare operations to improve quality and reduce costs also benefits the PCR technologies market in the US and other North American countries. An upsurge in the acceptance and adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that aid in rapid quantification, alterations, and observation. The emergence of digital PCR in the form of droplet digital PCR offers new opportunities for screening, providing superior sensitivity and easy adaptability. The US is seeking significant funding from public and private organizations to encourage investments in advanced research methodologies. For instance, the International Centre for Genetic Engineering and Biotechnology aims to stimulate collaborative research in the member states. It receives funds through the Collaborative Research Programme (CRP) that aims to address original scientific problems of relevance and interest. Advancements in biotechnology that depend on PCR techniques to help improve human health, animal welfare, and food security. The US Food and Drug Administration (USFDA) is committed to ensuring the safety of biotechnology products. The US actively participates in various research groups and organizations to conduct scientific conferences, workshops, and events that help exchange the trends and latest research studies based on PCR within different geographies. Therefore, the country's active involvement is also one of the factors driving the growth of the PCR technologies market.

North America PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

North America PCR Technologies Market Segmentation

The North America PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the North America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of North America PCR technologies market in 2022.

In terms of offerings, the North America PCR technologies market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of North America PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR and portable thermocyclers/PCR.

By application, the North America PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of North America PCR technologies market in 2022.

Based on end user, the North America PCR technologies market is categorized into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of North America PCR technologies market in 2022.

By country, the North America PCR technologies market has been categorized into the US, Canada, and Mexico. The US dominated the North America PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Atila Biosystems Inc, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, Visby Medical Inc, and Ellume Ltd are some of the leading companies operating in the North America PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - North America Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. North America PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. North America PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. North America PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. North America PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. North America PCR Technologies Market - Country Analysis

  • 10.1 North America: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 North America PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 United States
        • 10.1.2.1.1 Overview
      • 10.1.2.2 United States PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 United States PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 United States PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 United States PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 United States PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 United States PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 United States PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 United States PCR Technologies Market Breakdown by End User
      • 10.1.2.3 Canada
        • 10.1.2.3.1 Overview
      • 10.1.2.4 Canada PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 Canada PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 Canada PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 Canada PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 Canada PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 Canada PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 Canada PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 Canada PCR Technologies Market Breakdown by End User
      • 10.1.2.5 Mexico
        • 10.1.2.5.1 Overview
      • 10.1.2.6 Mexico PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 Mexico PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 Mexico PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 Mexico PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 Mexico PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 Mexico PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 Mexico PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 Mexico PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Atila Biosystems Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Takara Bio Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Standard Biotools Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Agilent Technologies Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Visby Medical Inc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Ellume Ltd
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 31. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 32. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. North America: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. North America PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Growth Strategies in the PCR Technologies Market